EFV was more likely to achieve virologic success than NVP, though marginally significant, in both randomised controlled trials (RR 1.04 [1.00–1.08] I 2 = 0%) and observational studies (RR 1.06 [1.00–1.12] I 2 = 68%).
← all excerpts
Outcomes for efavirenz versus nevirapine-containing regimens for treatment of HIV-1 infection: a systematic review and meta-analysis.
2
—
—
The sentences
Virologic Success There was a marginal significance between the two drugs, with EFV being more likely to achieve virological success compared to NVP.